American International Group, Inc. Arvinas, Inc. Transaction History

American International Group, Inc.

  • $27.6 Billion
  • Q1 2024

A detailed history of American International Group, Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 24,857 shares of ARVN stock, worth $661,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,857
Previous 24,408 1.84%
Holding current value
$661,693
Previous $1 Million 2.19%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$36.38 - $52.31 $16,334 - $23,487
449 Added 1.84%
24,857 $1.03 Million
Q4 2023

Feb 13, 2024
SELL
$14.19 - $42.33 $1,404 - $4,190
-99 Reduced 0.4%
24,408 $1 Million
Q3 2023

Nov 13, 2023
BUY
$19.64 - $28.21 $17,126 - $24,599
872 Added 3.69%
24,507 $481,000
Q2 2023

Aug 04, 2023
BUY
$21.73 - $31.43 $3,411 - $4,934
157 Added 0.67%
23,635 $586,000
Q1 2023

May 12, 2023
BUY
$26.15 - $37.26 $12,238 - $17,437
468 Added 2.03%
23,478 $641,000
Q4 2022

Feb 10, 2023
SELL
$32.47 - $57.24 $2,727 - $4,808
-84 Reduced 0.36%
23,010 $787,000
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $13,691 - $18,962
327 Added 1.44%
23,094 $1.03 Million
Q2 2022

Aug 12, 2022
SELL
$36.01 - $74.24 $22,398 - $46,177
-622 Reduced 2.66%
22,767 $958,000
Q1 2022

May 13, 2022
SELL
$60.27 - $81.57 $99,204 - $134,264
-1,646 Reduced 6.57%
23,389 $1.57 Million
Q4 2021

Feb 11, 2022
BUY
$65.85 - $96.21 $75,398 - $110,160
1,145 Added 4.79%
25,035 $2.06 Million
Q3 2021

Nov 12, 2021
SELL
$73.2 - $107.87 $41,577 - $61,270
-568 Reduced 2.32%
23,890 $1.96 Million
Q2 2021

Aug 13, 2021
BUY
$60.45 - $84.26 $204,139 - $284,546
3,377 Added 16.02%
24,458 $1.88 Million
Q1 2021

May 07, 2021
BUY
$58.19 - $91.37 $57,666 - $90,547
991 Added 4.93%
21,081 $1.39 Million
Q4 2020

Feb 12, 2021
BUY
$20.19 - $84.93 $52,534 - $220,987
2,602 Added 14.88%
20,090 $1.71 Million
Q3 2020

Nov 04, 2020
SELL
$22.99 - $36.34 $9,150 - $14,463
-398 Reduced 2.23%
17,488 $413,000
Q2 2020

Aug 12, 2020
BUY
$29.88 - $56.74 $159,200 - $302,310
5,328 Added 42.43%
17,886 $600,000
Q1 2020

May 04, 2020
SELL
$33.0 - $54.5 $23,958 - $39,567
-726 Reduced 5.47%
12,558 $506,000
Q4 2019

Feb 05, 2020
BUY
$15.39 - $44.38 $26,101 - $75,268
1,696 Added 14.64%
13,284 $546,000
Q3 2019

Nov 08, 2019
BUY
$21.55 - $27.61 $8,663 - $11,099
402 Added 3.59%
11,588 $250,000
Q2 2019

Aug 13, 2019
BUY
$15.96 - $23.8 $99,430 - $148,274
6,230 Added 125.71%
11,186 $246,000
Q1 2019

May 06, 2019
SELL
$13.55 - $23.79 $2,181 - $3,830
-161 Reduced 3.15%
4,956 $73,000
Q4 2018

Feb 13, 2019
BUY
$11.19 - $18.56 $57,259 - $94,971
5,117 New
5,117 $66,000

Others Institutions Holding ARVN

# of Institutions
234
Shares Held
64.9M
Call Options Held
119K
Put Options Held
94.2K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.42B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email